AAAAAA

   
Results: 1-16 |
Results: 16
Methods used to assess pulmonary deposition and absorption of drugs
Authors: Mobley, C Hochhaus, G
Citation: C. Mobley et G. Hochhaus, Methods used to assess pulmonary deposition and absorption of drugs, DRUG DISC T, 6(7), 2001, pp. 367-375
Evaluation of pulmonary absorption using pharmacokinetic methods
Authors: Derendorf, H Hochhaus, G Mollmann, H
Citation: H. Derendorf et al., Evaluation of pulmonary absorption using pharmacokinetic methods, J AEROSOL M, 14, 2001, pp. S9-S17
Pharmacokinetics of plasmid DNA in the rat
Authors: Houk, BE Martin, R Hochhaus, G Hughes, JA
Citation: Be. Houk et al., Pharmacokinetics of plasmid DNA in the rat, PHARM RES, 18(1), 2001, pp. 67-74
Pharmacokinetics and rectal bioavailability of hydrocortisone acetate after single and multiple administration in healthy subjects and patients
Authors: Tromm, A Mollmann, H Barth, J Hochhaus, G Krieg, M Bigalke, C Mollmann, A Derendorf, H
Citation: A. Tromm et al., Pharmacokinetics and rectal bioavailability of hydrocortisone acetate after single and multiple administration in healthy subjects and patients, J CLIN PHAR, 41(5), 2001, pp. 536-541
Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: A comparison with dexamethasone phosphate (DP)
Authors: Hochhaus, G Barth, J Al-Fayoumi, S Suarez, S Derendorf, H Hochhaus, R Mollmann, H
Citation: G. Hochhaus et al., Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: A comparison with dexamethasone phosphate (DP), J CLIN PHAR, 41(4), 2001, pp. 425-434
Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus((R)) or Turbohaler((R)) dry-powder inhalers to healthy subjects
Authors: Mollmann, H Wagner, M Krishnaswami, S Dimova, H Tang, Y Falcoz, C Daley-Yates, PT Krieg, M Stockmann, R Barth, J Lawlor, C Mollmann, AC Derendorf, H Hochhaus, G
Citation: H. Mollmann et al., Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus((R)) or Turbohaler((R)) dry-powder inhalers to healthy subjects, J CLIN PHAR, 41(12), 2001, pp. 1329-1338
Pharmacokinetic considerations in the design of pulmonary drug delivery systems for glucocorticoids
Authors: Mobley, C Hochhaus, G
Citation: C. Mobley et G. Hochhaus, Pharmacokinetic considerations in the design of pulmonary drug delivery systems for glucocorticoids, DRUG PHARM, 115, 2001, pp. 51-83
A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma
Authors: Krishnaswami, S Mollmann, H Derendorf, H Hochhaus, G
Citation: S. Krishnaswami et al., A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma, J PHARM B, 22(1), 2000, pp. 123-129
Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20th century
Authors: Hochhaus, G Barrett, JS Derendorf, H
Citation: G. Hochhaus et al., Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20th century, J CLIN PHAR, 40(9), 2000, pp. 908-917
Optimized therapeutic ratio of inhaled corticosteroids using retrometabolism
Authors: Derendorf, H Hochhaus, G Krishnaswami, S Meibohm, B Mollmann, H
Citation: H. Derendorf et al., Optimized therapeutic ratio of inhaled corticosteroids using retrometabolism, PHARMAZIE, 55(3), 2000, pp. 223-227
Loteprednol etabonate: A soft steroid for the treatment of allergic diseases of the airways
Authors: Szelenyi, I Hochhaus, G Heer, S Kusters, S Marx, D Poppe, H Engel, J
Citation: I. Szelenyi et al., Loteprednol etabonate: A soft steroid for the treatment of allergic diseases of the airways, DRUGS TODAY, 36(5), 2000, pp. 313-320
Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids
Authors: Meibohm, B Derendorf, H Mollmann, H Frohlich, P Tromm, A Wagner, M Homrighausen, S Krieg, M Hochhaus, G
Citation: B. Meibohm et al., Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids, INT J CL PH, 37(8), 1999, pp. 367-376
Analysis of leucine enkephalin by high-performance liquid chromatography using enzymatic derivatization by tyrosinase and electrochemical or fluorescence detection
Authors: Larsimont, V Bogaards, M Mulleneers, P Hochhaus, G
Citation: V. Larsimont et al., Analysis of leucine enkephalin by high-performance liquid chromatography using enzymatic derivatization by tyrosinase and electrochemical or fluorescence detection, J PHARM B, 19(6), 1999, pp. 855-864
A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids
Authors: Meibohm, B Hochhaus, G Mollmann, H Barth, J Wagner, M Krieg, M Stockmann, R Derendorf, H
Citation: B. Meibohm et al., A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids, J PHAR BIOP, 27(2), 1999, pp. 127-147
Assessment of complex peptide degradation pathways via structured multicompartmental modeling approaches: The metabolism of dynorphin A1-13 and related fragments in human plasma
Authors: Muller, S Hutson, A Arya, V Hochhaus, G
Citation: S. Muller et al., Assessment of complex peptide degradation pathways via structured multicompartmental modeling approaches: The metabolism of dynorphin A1-13 and related fragments in human plasma, J PHARM SCI, 88(9), 1999, pp. 938-944
Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy
Authors: Buchwald, A Hochhaus, G
Citation: A. Buchwald et G. Hochhaus, Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy, INT J CL PH, 36(12), 1998, pp. 652-660
Risultati: 1-16 |